Trinity Biotech amends Perceptive Advisors financing, adds USD 7 million investment
I'm LongbridgeAI, I can summarize articles.Trinity Biotech has amended its financing arrangement with Perceptive Advisors to secure an additional USD 7 million investment. This funding consists of approximately USD 2.5 million in new debt and USD 4.5 million in capitalized interest. The capital is intended to support strategic growth initiatives, specifically the CGM+ platform and Trinovium, as well as broader business transformation efforts.
- Trinity Biotech secured an additional USD 7 million investment from Perceptive Advisors under an amendment to existing financing arrangements. * Total comprises about USD 2.5 million of new debt funding, with about USD 4.5 million of capitalised interest. * Funding aims to support strategic growth initiatives, including the CGM+ platform, Trinovium, and a broader business transformation. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trinity Biotech plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001554855-26-001851), on August 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here